US Stock MarketDetailed Quotes

IKNA Ikena Oncology

Watchlist
  • 1.515
  • -0.055-3.50%
Trading Dec 27 10:20 ET
73.11MMarket Cap-1.23P/E (TTM)

Ikena Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
55.30%-8.94M
31.09%-12.5M
7.48%-18.3M
-7.60%-79.74M
-23.59%-21.82M
-16.13%-20M
6.72%-18.14M
0.00%-19.78M
-23.00%-74.11M
-32.07%-17.66M
Net income from continuing operations
40.99%-10.23M
19.78%-13.73M
-13.55%-16.15M
0.87%-68.17M
-38.25%-19.49M
-0.03%-17.34M
16.48%-17.12M
15.56%-14.22M
-101.57%-68.77M
-604.00%-14.1M
Operating gains losses
--0
--0
--99K
-97.30%5K
--0
--0
----
----
--185K
--0
Depreciation and amortization
-62.81%90K
-61.98%92K
-5.19%219K
35.82%1.02M
45.24%305K
13.62%242K
63.51%242K
28.33%231K
38.05%751K
28.83%210K
Other non cash items
31.42%619K
34.30%462K
32.05%445K
33.59%1.71M
70.30%562K
44.92%471K
8.86%344K
8.01%337K
9.28%1.28M
7.84%330K
Change In working capital
98.66%-64K
93.75%-181K
30.67%-5.27M
-43.14%-21.67M
-8.10%-6.38M
-110.37%-4.79M
-83.41%-2.9M
-41.35%-7.6M
54.17%-15.14M
67.59%-5.9M
-Change in receivables
119.82%132K
49.24%-501K
-123.57%-157K
-886.25%-2.87M
-2,115.29%-1.88M
42.49%-666K
-204.11%-987K
16,550.00%666K
-180.61%-291K
-118.68%-85K
-Change in prepaid assets
-119.56%-194K
673.80%2.63M
-220.45%-371K
106.59%11K
-249.73%-831K
-52.92%992K
82.78%-458K
282.25%308K
94.37%-167K
265.13%555K
-Change in payables and accrued expense
120.75%684K
-289.87%-1.72M
-28.95%-3.76M
-443.50%-7.66M
-301.37%-2.35M
-193.96%-3.3M
9.40%908K
-91.66%-2.92M
71.80%2.23M
-134.57%-586K
-Change in other current liabilities
-8.54%-686K
-64.04%-584K
-183.77%-979K
-54.02%-1.99M
-94.38%-657K
-90.94%-632K
-12.66%-356K
-12.38%-345K
-74.59%-1.29M
-12.67%-338K
-Change in other working capital
----
----
----
41.35%-9.16M
87.91%-659K
81.49%-1.19M
-425.72%-2M
-57.00%-5.31M
49.59%-15.62M
73.04%-5.45M
Cash from discontinued investing activities
Operating cash flow
55.30%-8.94M
31.09%-12.5M
7.48%-18.3M
-7.60%-79.74M
-23.59%-21.82M
-16.13%-20M
6.72%-18.14M
0.00%-19.78M
-23.00%-74.11M
-32.07%-17.66M
Investing cash flow
Cash flow from continuing investing activities
-70.36%9.45M
-82.72%3.92M
-351.03%-48.74M
164.61%64.14M
94.08%20.38M
-10.87%31.89M
10.71%22.68M
93.49%-10.81M
-5,541.14%-99.28M
2,008.91%10.5M
Net PPE purchase and sale
--190K
4,525.00%185K
139.47%60K
71.07%-414K
-15.15%-266K
--0
111.11%4K
-360.61%-152K
18.69%-1.43M
58.00%-231K
Net investment purchase and sale
-70.95%9.26M
-83.54%3.73M
-358.03%-48.8M
165.97%64.56M
92.38%20.64M
-13.60%31.89M
10.50%22.68M
93.58%-10.65M
---97.85M
--10.73M
Cash from discontinued investing activities
Investing cash flow
-70.36%9.45M
-82.72%3.92M
-351.03%-48.74M
164.61%64.14M
94.08%20.38M
-10.87%31.89M
10.71%22.68M
93.49%-10.81M
-5,541.14%-99.28M
2,008.91%10.5M
Financing cash flow
Cash flow from continuing financing activities
0
6,838.81%75.98M
5,900.00%60K
162,058.33%38.92M
-99.17%1.1M
-99.58%1K
Net common stock issuance
--0
----
----
--36.76M
--0
---123K
----
----
--0
--0
Net preferred stock issuance
----
----
----
--40.03M
----
----
----
----
--0
----
Proceeds from stock option exercised by employees
--0
----
----
-87.58%136K
--0
-37.50%15K
----
----
88.14%1.1M
-99.58%1K
Net other financing activities
----
----
----
---944K
---39.97M
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
--0
----
----
6,838.81%75.98M
5,900.00%60K
162,058.33%38.92M
----
----
-99.17%1.1M
-99.58%1K
Net cash flow
Beginning cash position
-36.51%45.55M
79.23%54.13M
99.33%121.17M
-73.92%60.79M
80.37%122.56M
45.34%71.74M
-36.75%30.2M
-73.92%60.79M
42.68%233.09M
-72.47%67.95M
Current changes in cash
-98.98%516K
-120.66%-8.58M
-119.16%-67.04M
135.04%60.38M
80.67%-1.38M
173.39%50.82M
2,480.06%41.54M
83.50%-30.59M
-347.11%-172.3M
47.71%-7.16M
End cash Position
-62.42%46.06M
-36.51%45.55M
79.23%54.13M
99.33%121.17M
99.33%121.17M
80.37%122.56M
45.34%71.74M
-36.75%30.2M
-73.92%60.79M
-73.92%60.79M
Free cash flow
55.30%-8.94M
31.09%-12.5M
8.19%-18.3M
-6.11%-80.16M
-23.45%-22.08M
-8.98%-20M
6.90%-18.14M
-0.60%-19.94M
-21.82%-75.54M
-28.51%-17.89M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 55.30%-8.94M31.09%-12.5M7.48%-18.3M-7.60%-79.74M-23.59%-21.82M-16.13%-20M6.72%-18.14M0.00%-19.78M-23.00%-74.11M-32.07%-17.66M
Net income from continuing operations 40.99%-10.23M19.78%-13.73M-13.55%-16.15M0.87%-68.17M-38.25%-19.49M-0.03%-17.34M16.48%-17.12M15.56%-14.22M-101.57%-68.77M-604.00%-14.1M
Operating gains losses --0--0--99K-97.30%5K--0--0----------185K--0
Depreciation and amortization -62.81%90K-61.98%92K-5.19%219K35.82%1.02M45.24%305K13.62%242K63.51%242K28.33%231K38.05%751K28.83%210K
Other non cash items 31.42%619K34.30%462K32.05%445K33.59%1.71M70.30%562K44.92%471K8.86%344K8.01%337K9.28%1.28M7.84%330K
Change In working capital 98.66%-64K93.75%-181K30.67%-5.27M-43.14%-21.67M-8.10%-6.38M-110.37%-4.79M-83.41%-2.9M-41.35%-7.6M54.17%-15.14M67.59%-5.9M
-Change in receivables 119.82%132K49.24%-501K-123.57%-157K-886.25%-2.87M-2,115.29%-1.88M42.49%-666K-204.11%-987K16,550.00%666K-180.61%-291K-118.68%-85K
-Change in prepaid assets -119.56%-194K673.80%2.63M-220.45%-371K106.59%11K-249.73%-831K-52.92%992K82.78%-458K282.25%308K94.37%-167K265.13%555K
-Change in payables and accrued expense 120.75%684K-289.87%-1.72M-28.95%-3.76M-443.50%-7.66M-301.37%-2.35M-193.96%-3.3M9.40%908K-91.66%-2.92M71.80%2.23M-134.57%-586K
-Change in other current liabilities -8.54%-686K-64.04%-584K-183.77%-979K-54.02%-1.99M-94.38%-657K-90.94%-632K-12.66%-356K-12.38%-345K-74.59%-1.29M-12.67%-338K
-Change in other working capital ------------41.35%-9.16M87.91%-659K81.49%-1.19M-425.72%-2M-57.00%-5.31M49.59%-15.62M73.04%-5.45M
Cash from discontinued investing activities
Operating cash flow 55.30%-8.94M31.09%-12.5M7.48%-18.3M-7.60%-79.74M-23.59%-21.82M-16.13%-20M6.72%-18.14M0.00%-19.78M-23.00%-74.11M-32.07%-17.66M
Investing cash flow
Cash flow from continuing investing activities -70.36%9.45M-82.72%3.92M-351.03%-48.74M164.61%64.14M94.08%20.38M-10.87%31.89M10.71%22.68M93.49%-10.81M-5,541.14%-99.28M2,008.91%10.5M
Net PPE purchase and sale --190K4,525.00%185K139.47%60K71.07%-414K-15.15%-266K--0111.11%4K-360.61%-152K18.69%-1.43M58.00%-231K
Net investment purchase and sale -70.95%9.26M-83.54%3.73M-358.03%-48.8M165.97%64.56M92.38%20.64M-13.60%31.89M10.50%22.68M93.58%-10.65M---97.85M--10.73M
Cash from discontinued investing activities
Investing cash flow -70.36%9.45M-82.72%3.92M-351.03%-48.74M164.61%64.14M94.08%20.38M-10.87%31.89M10.71%22.68M93.49%-10.81M-5,541.14%-99.28M2,008.91%10.5M
Financing cash flow
Cash flow from continuing financing activities 06,838.81%75.98M5,900.00%60K162,058.33%38.92M-99.17%1.1M-99.58%1K
Net common stock issuance --0----------36.76M--0---123K----------0--0
Net preferred stock issuance --------------40.03M------------------0----
Proceeds from stock option exercised by employees --0---------87.58%136K--0-37.50%15K--------88.14%1.1M-99.58%1K
Net other financing activities ---------------944K---39.97M--------------------
Cash from discontinued financing activities
Financing cash flow --0--------6,838.81%75.98M5,900.00%60K162,058.33%38.92M---------99.17%1.1M-99.58%1K
Net cash flow
Beginning cash position -36.51%45.55M79.23%54.13M99.33%121.17M-73.92%60.79M80.37%122.56M45.34%71.74M-36.75%30.2M-73.92%60.79M42.68%233.09M-72.47%67.95M
Current changes in cash -98.98%516K-120.66%-8.58M-119.16%-67.04M135.04%60.38M80.67%-1.38M173.39%50.82M2,480.06%41.54M83.50%-30.59M-347.11%-172.3M47.71%-7.16M
End cash Position -62.42%46.06M-36.51%45.55M79.23%54.13M99.33%121.17M99.33%121.17M80.37%122.56M45.34%71.74M-36.75%30.2M-73.92%60.79M-73.92%60.79M
Free cash flow 55.30%-8.94M31.09%-12.5M8.19%-18.3M-6.11%-80.16M-23.45%-22.08M-8.98%-20M6.90%-18.14M-0.60%-19.94M-21.82%-75.54M-28.51%-17.89M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Cisco
CSCO
-0.48%
ASML Holding
ASML
-0.66%
Disney
DIS
-1.06%
Salesforce
CRM
-1.14%
Adobe
ADBE
-1.26%

Unlock the Full List